Note: Not all studies are available based on copyrights of the original documents. Please note the PARI Pharma copyright studies are owned by PARI Pharma. Data may not be referenced in any way including print and electronic formats without the prior written consent of PARI Pharma.

[DDL 12-01 018] A. Balcke, D. Jahn, P. Stempfle, U. Schuschnig, M. Keller: Effect of operating pressure, drug concentration and volume fill on the nebulisation efficiency of jet nebulisers. DDL XII, London, December 13-14, 2001; pp. 183 - 186. [DDL 12-01 017] J. Jauernig, D. Jahn, P. Stempfle, A. Balcke, M. Keller: In-vitro assessment of a PARI LC PLUS® nebuliser utilising a standard inhalation pattern compared to breathing profiles of 3 Cystic Fibrosis (CF) patients. DDL XII, London, December 13-14, 2001; pp. 179 - 182.
[DDL 12-01 016] M. Keller, F.-C. Lintz and E. Walther: Novel liquid formulation technologies as a tool to design the aerosol performance of nebulisers using an air jet (LC PLUS®) or a vibrating membrane principle (eFlow™). DDL XII, London, December 13-14, 2001; pp. 99 - 102. [DDL 12-01 015] J. Smart, R. Stangl, I. Halsall, H. Chrystyn: TochSpray™ Technology: Preliminary results from the in-vitro evaluation of Insulin and Albumin. DDL XII, London, December 13-14, 2001; pp. 103 - 106.
[DDL 12-01 014] R. Stangl: The PARI e-Flow™: Tools in the Development Process of a New Inhaler for Topic and Systemic Pulmonary Drug Delivery. DDL XII, London, December 13-14, 2001; pp. 107 - 110. [AAPS 10-01 013] A. Bucholski, A. Balcke, P. Stempfle, M. Keller: Comparison of mass spectrometric and evaporative light scattering detection for direct quantification of tobramycin in inhalation solutions. AAPS Annual Meeting, October 21-25, 2001, (poster presentation No. M2130).
[AAPS 10-01 012] F.-C. Lintz, E. Walther, R. Waldner, M. Keller: Influence of viscosity and surface tension on the nebulization efficiency of a Jet (LC PLUS®) and a vibrating membrane type nebulizer (eFlow™). AAPS Annual Meeting, October 21-25, 2001, (poster presentation No. M2133).
[ISAM 09-01 011] A. Balcke, D. Jahn, A. Bucholski, P. Stempfle, U. Schuschnig, M. Keller, M. Knoch: Effect of different nebulizer / compressor configurations on the nebulization efficiency of a salbutamol solution. 13th International Congress of the International Society for Aerosols in Medicine (ISAM), Interlaken, September 17-21, 2001; Proceedings p. 390, (poster presentation, No.: P1 - 22).
[ISAM 09-01 010] A. Bucholski, A. Balcke, P. Stempfle, M. Keller: Quantification of tobramycin in inhalation solutions by HPLC utilizing mass spectrometric and evaporative light scattering detection. 13th International Congress of the International Society for Aerosols in Medicine (ISAM), Interlaken, September 17-21, 2001; Proceedings p. 389, (poster presentation, No.: P1 - 18).
[ISAM 09-01 009] J. Jauernig, U. Schuschnig, C. Hinrichs, C. Hug, M. Keller: Comparative assessment of the Aerodynamic droplet deposition pattern in an Andersen and Marple 298 impactor. 13th International Congress of the International Society for Aerosols in Medicine (ISAM), Interlaken, September 17-21, 2001; Proceedings p. 405, (abstract).
[ISAM 09-01 008] F.-C. Lintz, E. Walther, M. Keller: Effect of novel pharmaceutical formulations on nebulization efficiency of a common (PARI LC STAR®) and new electronic nebuliser (eFlow™). 13th International Congress of the International Society for Aerosols in Medicine (ISAM), Interlaken, September 17-21, 2001; Proceedings p. 390, (poster presentation, No.: P1 - 23).
[ISAM 09-01 007] M. Knoch: New Prospects in Nebulized Drug Delivery. 13th ISAM Congress, Interlaken, September 17-21, 2001; Proceedings p. 381, (abstract and oral presentation).
[ISAM 09-01 006] E. Sommer, N. Luangkhot: Assessment of a New System for Monitoring Aerosol Output of Breath Enhanced Nebulizers. 13th ISAM Congress, Interlaken, September 17. - 21., 2001; Proceedings p. 410, (poster presentation, No.: P3 - 15).
[ISAM 09-01 005] Stangl, D. Häuser, M. Hug, J. Jauernig, R. Waldner: Comparing Particle/Droplet Image Analysis (PDIA) with other Particle Sizing Methods. 13th International Congress of the International Society for Aerosols in Medicine (ISAM), Interlaken, September 17-21, 2001; Proceedings p. 416, (poster presentation, No.: P3 - 41).
[ECFC 06-01 004] M. Keller, J. Jauernig, U. Schuschnig, A. Balcke, D. Jahn, C. Hinrichs, F.-C. Lintz, E. Walther: Effect of individual CF-Patients´ Breathing Profiles on the Delivery Efficiency of a PARI LC PLUS Nebuliser utilising a Tobramycin solution. European CF Conference, Vienna, June 6-9, 2001, (poster presentation, No.: 187).
[ECFC 06-01 002] M. Keller and F.-C. Lintz: New liquid formulation technologies for inhalation products. European CF Conference, Vienna, June 6-9, 2001, (oral presentation).
[ECFC 06-01 001] M. Knoch: The PARI eFlow™ technology: A new aerosol delivery platform for liquid medication. European CF Conference, Vienna, June 6-9, 2001, (oral presentation).R. Stangl: An Overview of Innovative Inhalation Devices; European Pharmaceutical Review; Issue 4, 2001, p. 50 – 55;